Trade Faes Farma, S.A. - FAE CFD
Add to favourite- Summary
- Historical Data
Spread | 0.02 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.017952% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.004271% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 10 | ||||||||
Currency | EUR | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Spain | ||||||||
Commission on trade | 0% |
Prev. Close | 4.01 |
Open | 4.03 |
1-Year Change | 27.94% |
Day's Range | 4.03 - 4.13 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 23, 2025 | 4.12 | 0.09 | 2.23% | 4.03 | 4.14 | 4.02 |
Apr 22, 2025 | 4.01 | 0.15 | 3.89% | 3.86 | 4.04 | 3.84 |
Apr 17, 2025 | 3.87 | 0.03 | 0.78% | 3.84 | 3.89 | 3.84 |
Apr 16, 2025 | 3.85 | 0.05 | 1.32% | 3.80 | 3.85 | 3.79 |
Apr 15, 2025 | 3.79 | 0.06 | 1.61% | 3.73 | 3.80 | 3.72 |
Apr 14, 2025 | 3.72 | 0.00 | 0.00% | 3.72 | 3.75 | 3.69 |
Apr 11, 2025 | 3.69 | 0.04 | 1.10% | 3.65 | 3.71 | 3.57 |
Apr 10, 2025 | 3.64 | -0.05 | -1.36% | 3.69 | 3.74 | 3.62 |
Apr 9, 2025 | 3.59 | -0.07 | -1.91% | 3.66 | 3.69 | 3.55 |
Apr 8, 2025 | 3.77 | 0.06 | 1.62% | 3.71 | 3.79 | 3.67 |
Apr 7, 2025 | 3.71 | -0.03 | -0.80% | 3.74 | 3.81 | 3.63 |
Apr 4, 2025 | 3.88 | -0.17 | -4.20% | 4.05 | 4.08 | 3.82 |
Apr 3, 2025 | 4.07 | 0.12 | 3.04% | 3.95 | 4.08 | 3.95 |
Apr 2, 2025 | 4.02 | 0.03 | 0.75% | 3.99 | 4.04 | 3.93 |
Apr 1, 2025 | 3.91 | -0.01 | -0.26% | 3.92 | 4.00 | 3.87 |
Mar 31, 2025 | 3.92 | -0.05 | -1.26% | 3.97 | 3.98 | 3.81 |
Mar 28, 2025 | 3.98 | -0.04 | -1.00% | 4.02 | 4.05 | 3.92 |
Mar 27, 2025 | 4.03 | 0.20 | 5.22% | 3.83 | 4.05 | 3.83 |
Mar 26, 2025 | 3.88 | 0.25 | 6.89% | 3.63 | 4.00 | 3.58 |
Mar 25, 2025 | 3.52 | 0.04 | 1.15% | 3.48 | 3.57 | 3.47 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Faes Farma Company profile
About FAES Farma SA
Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, FAES Farma SA revenues increased 5% to EUR398.6M. Net income increased 15% to EUR83.2M. Revenues reflect Speciality Pharmaceuticals segment increase of 5% to EUR336.8M, Nutrition & Animals Care Products segment increase of 6% to EUR60.3M, Domestic Market (Spain) segment increase of 11% to EUR307.3M. Net income benefited from Provisions decrease of 74% to EUR1.5M (expense).
Equity composition
05/2005, Scrip Issue, 1 new share for every 8 shares held. 03/2006, Scrip Issue, 1 new share for every 8 shares held. 01/2007, 2-for-1 stock split. 04/2007, Scrip Issue, 1 new share for every 8 shares held. 04/2008, Scrip Issue, 1 new share for every 8 shares held. 03/2009, Scrip Issue, 1 new share for every 8 shares held. => Note section
Industry: | Pharmaceuticals (NEC) |
Parque Empresarial Cristalia. Calle Vía de los Poblados 3, Edificio 2, 2º Izquierda
MADRID
MADRID 28033
ES
News

ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com